SIR 2024
Interventional Oncology
Kyle M. Schachtschneider, PhD (he/him/his)
Vice President of R&D, Services
Sus Clinicals Inc.
Financial relationships: Full list of relationships is listed on the CME information page.
Matthew Niemeyer, MD
Assistant Professor
University of Illinois
Disclosure information not submitted.
Lawrence Schook, PhD
Chief Scientific Officer
Sus Clinicals Inc.
Disclosure information not submitted.